77 results
Page 4 of 4
6-K
EX-99.2
ba8nbhen1rhc5uibshue
13 Apr 22
Consolidated Financial Statements
7:22am
6-K
EX-99.1
ibyt rqlt4
12 Apr 22
XORTX Receives No Objection Letter from Health Canada
9:57am
6-K
EX-99.1
lme8ljt
7 Apr 22
XORTX Announces Grant of US Patent
7:00am
6-K
EX-99.1
rmsaex
23 Mar 22
XORTX Files New PCT Patent to Treat and Protect Individuals Most at Risk to Severe Viral Infection
7:00am
6-K
EX-99.1
jqy33m9t 97
14 Mar 22
XORTX Therapeutics Announces Submission of Clinical Trial Application to Conduct Bridging Pharmacokinetics Study
7:00am
6-K
EX-99.1
8x2q5z
21 Dec 21
XORTX Therapeutics Announces Filing of Provision Patent for Polycystic Kidney Disease
7:02am
6-K
EX-99.1
0e9bak
10 Dec 21
XORTX Therapeutics Announces Publication of Mt. Sinai Study of Hospitalized COVID-19 Patients
1:53pm
6-K
EX-99.2
y2v6yu
29 Nov 21
Condensed Interim Consolidated Financial Statements
12:00am
424B4
nt2mp5t7ewfad
14 Oct 21
Prospectus supplement with pricing info
4:30pm
F-1/A
cztj22u
4 Oct 21
Registration statement (foreign) (amended)
12:00am
F-1/A
fx8duxv26gkozilvr6
16 Sep 21
Registration statement (foreign) (amended)
5:16pm
F-1
l2fmg8uaei37f3u6ls
11 Aug 21
Registration statement (foreign)
9:55pm
DRS/A
ca3lsgp5tczdsya0nr
21 Jul 21
Draft registration statement (amended)
12:00am
DRSLTR
vazey2s21mchxthwswup
20 Jul 21
Correspondence regarding draft registration statement
12:00am
UPLOAD
pn3rju1iaf75j
28 Jun 21
Letter from SEC
12:00am
DRS
EX-10.1
b86tdef05dylr06z
26 May 21
Draft registration statement
12:00am
DRS
u7rgkil78cu9
26 May 21
Draft registration statement
12:00am